BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7805033)

  • 1. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas.
    Walker DG; Duan W; Popovic EA; Kaye AH; Tomlinson FH; Lavin M
    Cancer Res; 1995 Jan; 55(1):20-3. PubMed ID: 7805033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
    Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoblastoma gene is involved in malignant progression of astrocytomas.
    Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
    Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
    Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.
    Schmidt EE; Ichimura K; Reifenberger G; Collins VP
    Cancer Res; 1994 Dec; 54(24):6321-4. PubMed ID: 7987821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p.
    Ueki K; Rubio MP; Ramesh V; Correa KM; Rutter JL; von Deimling A; Buckler AJ; Gusella JF; Louis DN
    Hum Mol Genet; 1994 Oct; 3(10):1841-5. PubMed ID: 7849711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours.
    Miyakawa A; Ichimura K; Schmidt EE; Varmeh-Ziaie S; Collins VP
    Br J Cancer; 2000 Feb; 82(3):543-9. PubMed ID: 10682663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous deletions of the MTS1 gene are rare in non-astrocytic brain tumors.
    Walker DG; Duan W; Kaye AH; Lavin MF
    Biochem Biophys Res Commun; 1995 Jun; 211(2):404-9. PubMed ID: 7794250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
    Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
    Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus.
    Ichimura K; Schmidt EE; Yamaguchi N; James CD; Collins VP
    Cancer Res; 1994 Jun; 54(12):3127-30. PubMed ID: 8205529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A; Clark WC; Robertson JT; Ikejiri B; Oldfield EH; Ali IU
    Cancer Res; 1992 Dec; 52(23):6716-21. PubMed ID: 1358438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors.
    Frank S; Müller J; Plaschke J; Hahn M; Hampl J; Hampl M; Pistorius S; Schackert G; Schackert HK
    Cancer Res; 1997 Jul; 57(13):2638-41. PubMed ID: 9205070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
    Cairns P; Tokino K; Eby Y; Sidransky D
    Cancer Res; 1995 Jan; 55(2):224-7. PubMed ID: 7812948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.